Mandate

Vinge has advised AMF Pensionsförsäkring in connection with the entry into of an agreement concerning the acquisition of 89.9% of Bergvik Skog Öst from BillerudKorsnäs Skog & Industri

June 24, 2019 M&A

Vinge has advised AMF Pensionsförsäkring AB in connection with an acquisition of 89.9% of the shares in BSÖ Holding AB, the owner of Bergvik Skog Öst AB, from BillerudKorsnäs Skog and Industri Aktiebolag.

The company was valued at SEK 12.2 billion on a debt‑free and cash‑free basis and covers a total of 363 000 hectares of land of which 295 000 hectares are productive forestry land primarily situated in central Sweden. As a part of the transaction, a long‑term agreement was entered into with BillerudKorsnäs for delivery of timber. The investment is AMF’s first direct investment in forestry.

The transaction is conditional upon approval by the Swedish Competition Authority.

Vinge’s team primarily consisted of Jonas Johansson, Carl Sander and Vilhelm Rondahl (M&A), Assur Badur and Karolina Cohrs (Real Property), Thomas Sjöberg and Johan Cederblad (Environmental) and Mathilda Persson (Commercial Agreements and IT).

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025